166 related articles for article (PubMed ID: 12150330)
1. Immunohistochemical detection of E-cadherin, alpha- and beta-catenins in papillary thyroid carcinoma.
Kapran Y; Ozbey N; Molvalilar S; Sencer E; Dizdaroğlu F; Ozarmağan S
J Endocrinol Invest; 2002; 25(7):578-85. PubMed ID: 12150330
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant.
Rocha AS; Soares P; Seruca R; Máximo V; Matias-Guiu X; Cameselle-Teijeiro J; Sobrinho-Simões M
J Pathol; 2001 Jul; 194(3):358-66. PubMed ID: 11439369
[TBL] [Abstract][Full Text] [Related]
3. Expression of E-cadherin and alpha-, beta-, gamma-catenin proteins in endometrial carcinoma.
Kim YT; Choi EK; Kim JW; Kim DK; Kim SH; Yang WI
Yonsei Med J; 2002 Dec; 43(6):701-11. PubMed ID: 12497652
[TBL] [Abstract][Full Text] [Related]
4. Mucoepidermoid carcinoma of the thyroid: a tumour histotype characterised by P-cadherin neoexpression and marked abnormalities of E-cadherin/catenins complex.
Rocha AS; Soares P; Machado JC; Máximo V; Fonseca E; Franssila K; Sobrinho-Simões M
Virchows Arch; 2002 May; 440(5):498-504. PubMed ID: 12021924
[TBL] [Abstract][Full Text] [Related]
5. Expression of the cadherin-catenin complex in well-differentiated human thyroid neoplastic tissue.
Huang SH; Wu JC; Chang KJ; Liaw KY; Wang SM
Thyroid; 1999 Nov; 9(11):1095-103. PubMed ID: 10595458
[TBL] [Abstract][Full Text] [Related]
6. E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma.
Bukholm IK; Nesland JM; Kåresen R; Jacobsen U; Børresen-Dale AL
J Pathol; 1998 Jul; 185(3):262-6. PubMed ID: 9771479
[TBL] [Abstract][Full Text] [Related]
7. Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.
Endo K; Ueda T; Ueyama J; Ohta T; Terada T
Hum Pathol; 2000 May; 31(5):558-65. PubMed ID: 10836294
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer.
Choi YS; Shim YM; Kim SH; Son DS; Lee HS; Kim GY; Han J; Kim J
Eur J Cardiothorac Surg; 2003 Sep; 24(3):441-9. PubMed ID: 12965318
[TBL] [Abstract][Full Text] [Related]
9. Changes in the E-cadherin-catenin complex expression in early and advanced gastric cancers.
Joo YE; Rew JS; Kim HS; Choi SH; Park CS; Kim SJ
Digestion; 2001; 64(2):111-9. PubMed ID: 11684825
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin/α-catenin deregulated co-expression in thyroid carcinoma based on tissue microarray digital image analysis.
Tsiambas E; Ragos V; Georgakopoulos G; Rigopoulos DN; Fotiades PP; Chatziioannidis A; Stamatelopoulos A; Vilaras G; Karameris A
J BUON; 2016; 21(2):450-5. PubMed ID: 27273957
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between the expression of E-cadherin-catenins and alpha-, beta-, gamma-catenin and the metastasis and prognosis of breast cancer].
Zou W; Hu CH; Zhou JP
Hunan Yi Ke Da Xue Xue Bao; 2002 Dec; 27(6):499-502. PubMed ID: 12658921
[TBL] [Abstract][Full Text] [Related]
12. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
Yoshida R; Kimura N; Harada Y; Ohuchi N
Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480
[TBL] [Abstract][Full Text] [Related]
13. Beta- and gamma-catenin expression in thyroid carcinomas.
Cerrato A; Fulciniti F; Avallone A; Benincasa G; Palombini L; Grieco M
J Pathol; 1998 Jul; 185(3):267-72. PubMed ID: 9771480
[TBL] [Abstract][Full Text] [Related]
14. P-cadherin expression in breast carcinoma indicates poor survival.
Peralta Soler A; Knudsen KA; Salazar H; Han AC; Keshgegian AA
Cancer; 1999 Oct; 86(7):1263-72. PubMed ID: 10506713
[TBL] [Abstract][Full Text] [Related]
15. Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours.
Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
J Pathol; 2002 Feb; 196(2):154-62. PubMed ID: 11793366
[TBL] [Abstract][Full Text] [Related]
16. Expression of E-cadherin, alpha- and beta-catenins in patients with pancreatic adenocarcinoma.
Joo YE; Rew JS; Park CS; Kim SJ
Pancreatology; 2002; 2(2):129-37. PubMed ID: 12123093
[TBL] [Abstract][Full Text] [Related]
17. Expression of e-cadherin and catenins in early gastric cancer.
Joo YE; Rew JS; Choi SK; Bom HS; Park CS; Kim SJ
J Clin Gastroenterol; 2002 Jul; 35(1):35-42. PubMed ID: 12080224
[TBL] [Abstract][Full Text] [Related]
18. Role of E-cadherin, alpha-, beta-, and gamma-catenins, and p120 (cell adhesion molecules) in prolactinoma behavior.
Qian ZR; Li CC; Yamasaki H; Mizusawa N; Yoshimoto K; Yamada S; Tashiro T; Horiguchi H; Wakatsuki S; Hirokawa M; Sano T
Mod Pathol; 2002 Dec; 15(12):1357-65. PubMed ID: 12481018
[TBL] [Abstract][Full Text] [Related]
19. Expression of E-cadherin, alpha, beta and gamma-catenin in human colorectal cancer.
Hiscox S; Jiang WG
Anticancer Res; 1997; 17(2B):1349-54. PubMed ID: 9137497
[TBL] [Abstract][Full Text] [Related]
20. Expression of E-cadherin and catenins in invasive mammary carcinomas.
Zschiesche W; Schönborn I; Behrens J; Herrenknecht K; Hartveit F; Lilleng P; Birchmeier W
Anticancer Res; 1997; 17(1B):561-7. PubMed ID: 9066580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]